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Abstract
Background: Brooke-Spiegler syndrome (BSS) is probably an underdiagnosed ge-
nodermatosis that predisposes for the development of cylindromas, spiradeno-
mas and trichoepitheliomas mainly of the head and neck. Wide phenotypic varia-
bility regarding the number and type of lesions can be observed within a family.
Mutations of the CYLD gene are identified in the vast majority of cases and play
a key role in BSS pathogenesis.
Main observations: Two first degree relatives with numerous erythematous te-
langiectatic nodules of the scalp present for decades, with recurring tendency re-
gardless the multiple previous excisions. Histopathological review of the lesions
revealed predominantly "spiradenocylindromas" in the proband and cylindromas
in her sister. The suspicion of BSS was confirmed after detection of a new non-
sense germline mutation of CYLD (c.1783C>T pGln 595*) in the proband.
Conclusions: BSS diagnosis can be challenging and is based on clinical-patholo-
gical correlation, positive familial association and identification of CYLD mutations.
CYLD exerts antineoplastic effects by downregulating intracellular NF-κB signal-
ling pathways. The reported mutation affecting the ubiquitin-specific protease do-
main leads to a truncated and catalytically inactive enzyme. Despite the expanding
list of CYLD mutations no firm genotype-phenotype correlation is known so far.
Early recognition and treatment of BSS avoid disfiguring changes like "turban tu-
mor". (J Dermatol Case Rep. 2015; 9(3): 67-70)
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Introduction
Brooke-Spiegler syndrome (BSS; OMIM 605041) is a rare
hereditary disorder characterized by predisposition for mul-
tiple skin adnexal tumors derived from the folliculo-seba-
ceous-apocrine unit, specifically cylindromas, spiradeno-
mas and trichoepitheliomas.1,2
These tumors that are uncommon in the general popula-
tion, begin during adolescence, typically involving the scalp,
face and neck, and gradually increase in number and size
throughout life.3,4
The two ends within the phenotypic spectrum of BSS are
familial cylindromatosis (FC; OMIM 132700) and multiple
familial trichoepithelioma (MFT; MIM 601606), allelic disor-
ders that share germline mutations of the cylindromatosis
(CYLD) tumor-suppressor gene. Different manifestations of
each can be present to a variable degree within a single family.1-3
Apart from skin adnexal tumors, an increased incidence
of salivary gland, parathyroid and ovarian neoplasms has
been found in patients with BSS, as well as inflammatory
disorders such as ulcerative colitis. This probably reflects
the physiological importance and ubiquity of CYLD protein
expression.1,5,6
Despite the growing number of mutations reported over
the last decade, there is no defined genotype-phenotype
correlation in BSS.1,3,7
We describe two members of a family affected by multiple
nodular scalp lesions, present for decades and with clinical
and histological features consistent with BSS and confirmed
after identification of a new germline mutation of CYLD gene.
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Case reports
Proband: An 80-year-old Portuguese Caucasian woman
presented with multiple slowly growing papules and nodu-
les of the scalp, some episodically painful, which started du-
ring adolescence. Thirteen lesions were excised in a general
surgery department, due to pain and aesthetic discomfort,
but a dermatology evaluation was requested due to the emer-
gence of new scalp lesions. Clinical examination showed
multiple aggregated erythematous telangiectatic papules and
nodules on the scalp, sometimes lobulated, with elastic con-
sistency ranging in size from 1x1 to 2x3 cm (Fig. 1). Most le-
sions shared dermoscopic features of cylindromas with ar-
borizing telangiectasia and scattered white globules on a mil-
ky to salmon-pink background (Fig. 2). Excisional biopsy of
three nodules revealed, in all of them, a predominant spira-
denoma pattern, with multiple inter-anastomosing trabecu-
lae composed of a biphasic cell population (small cells with
hyperchromatic nuclei at the periphery and clear larger cells
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Figure 2
Dermatoscopic features of cylindroma within a scalp nodule. Ar-
borizing telangiectasia more pronounced at the periphery, scat-
tered white globules at the centre and a salmon-pink background.
Figure 1
Scalp lesions. Confluent erythema-
tous telangiectatic nodules and pa-
pules on the scalp of the proband,
consistent with spiradenocylindro-
mas and cylindromas.
Figure 4
Cylindroma pattern. Nests of basaloid cells in a "jigsaw" puzzle
pattern surrounded by a thick hyaline membrane. Tendency for
palisading of epithelial darker cells at the periphery.
Figure 3
Spiradenoma pattern. Multiple inter-anastomosing trabeculae
composed of small cells with hyperchromatic nuclei at the peri-
phery and clear larger cells at the centre. Sparse lymphocytic infiltrate.
at the centre) surrounded by a highly vascularized hyaline
stroma and with a sparse lymphocytic infiltrate (Fig. 3). Areas
of cylindroma were also seen, with nests of basaloid cells in
close apposition in a jigsaw puzzle-like pattern surrounded
by a thick hyaline membrane (Fig. 4). Histopathological re-
view of previously excised lesions confirmed the presence
of mainly "spiradenocylindromas", and less often cylindro-
mas and spiradenomas, raising the suspicion of BSS.
Case 2: The 77-year-old sister of the proband also presen-
ted similar scalp lesions for decades: aggregated erythema-
tous nodules with 2 to 3 cm in diameter, with smooth telan-
giectatic surface. Lesions began in the second decade of life
and five of themhad already been removed in another hospital
for esthetical reasons, with no histological evaluation known.
Two further symptomatic nodules that were excised corre-
sponded to typical cylindromas histologically.
Within the family, four of ten uncles had a history of mul-
tiple scalp lesions. Patients’ offspring were, so far, not affec-
ted by similar lesions.
In the presence of multiple adnexal scalp tumors with hi-
stological features of cylindroma and spiradenoma in two
first-degree relatives we considered the diagnosis of BSS.
The proband was assessed for CYLD gene germline muta-
tion in peripheral blood sample. A heterozygous nonsense
mutation was detected in exon 11 of CYLD gene, responsi-
ble for the introduction of a premature stop codon at posi-
tion 595 amino acid (c.1783C>T pGln 595*).
Patients referred no other complaints and clinical and ul-
trasound evaluation of salivary glands as well as abdominal
ultrasound were normal.
Discussion
BSS is probably an underdiagnosed autosomal dominant
genodermatosis, with variable but increasing penetrance
with age (60-100%), resulting from germline mutations in
theCYLD gene located on chromosome16q12-q13.1,3,8 These
mutations are found roughly in 80-85% of BSS cases.7 Ho-
wever, in the remaining cases one should take into account
that de novomutations of other germline genes, alterations
in noncoding regions, large chromosomal rearrangements
or deletions, or other changes not detected by conventional
sequencing can be present.2,7
CYLD gene consists of 20 exons, 17 of which translate an
evolutionarily conserved 120 kDa cytoplasmic protein be-
longing to the family of deubiquitinating enzymes.1,7 It exerts
a tumor suppressor effect by negative regulation of the in-
tracellular signalling pathways of NF-κB, JNK and Wnt.4,5
CYLD mutations ultimately increase NF-κB expression, le-
ading to resistance to apoptosis and facilitating tumor deve-
lopment.4,5 There are currently at least 93 known germline
mutations of CYLD, most of them involving its 3‘ terminal,
which translates the catalytic domain of the enzyme (exons
8-20).3 About 90% of the tumor-eliciting mutations result in
a truncated CYLD protein and are mainly of frameshift or
nonsense type.1,3,7
In our proband we detected a new germline heterozygo-
us mutation of CYLD, (c.1783C>T p.Gln595*), responsible
for the introduction of a premature stop codon. This muta-
tion in exon 11 (aa 595), at the beginning of ubiquitin-spe-
cific protease (USP) domain (aa 583-956) leads to the pro-
duction of a truncated and catalytically inactive enzyme. The
subsequent loss of heterozygosity of wild-type allele at CYLD
locus, or the (more frequent) occurrence of other somatic
mutations of CYLDmay be responsible for the development
of the lesions described.1,7
As in our cases, the lesions more frequently found in BSS
cases are cylindromas and spiradenomas. These closely-re-
lated tumors share the same anatomical distribution, have
controversial histogenesis and can occur close together in
the same patient. They are usually poorly differentiated, and
show overlapping cytomorphological and immunohistoche-
mical features of apocrine and eccrine lineage.8,9
Nevertheless, Sellheyer recently proposed that spiradeno-
mas and cylindromas are not sudoriparous but poorly diffe-
rentiated follicular tumors derived from the hair follicle bul-
ge. He based his proposal on the increased expression of
CD200 in both types of lesions whereas, in his extensive stu-
dy, he had shown that tumors classified as eccrine in line-
age (hidradenoma, poroma, dermal duct tumor, and hidro-
acanthoma simplex) were CD200 negative.9
Cylindromas are benign basaloid painless tumors distri-
buted preferentially over the areas that are rich in hair follic-
les and sebaceous glands, typically begin during puberty al-
though sometimes earlier, grow slowly and affect mainly wo-
men, with a ratio 6-9:1.1,3,8,10 Clinically they consist of no-
dular erythematous lesions with overlying telangiectasia and
variable size distributed over the scalp, face and neck, whe-
reas the trunk, extremities and the pubic region are less af-
fected.3,10 Multiple cylindromas may coalesce in the scalp
and form the so-called turban tumor.1,7,10 Malignant trans-
formation of cylindromas may occur with an aggressive be-
haviour in the context of BSS, characterized by rapid growth,
pink-blue colour, ulceration and haemorrhage.3 The repor-
ted dermatoscopic features of cylindroma include arborizing
vessels more pronounced at the periphery on a whitish-pin-
kish background, blue dots and globules and ulceration.11
These findings are similar to those observed in the excised
spiradenocylindromas of the proband. Histologically, cylin-
dromas are non-encapsulated dermal nodules composed of
islands and cords of basaloid cells, apposed in a jigsaw-puzzle
pattern and surrounded by a thick, hyaline, PAS-positive ba-
sement membrane. Epithelial cells at the periphery of the is-
lands have a tendency for palisading and are darker than
those located in the centre of the nodules.1,12
Spiradenomas typically present as purple to bluish nodu-
les of variable size in nearly any location, and can be asso-
ciated with paroxystic pain. They commonly occur together
with cylindromas, giving rise to spiradenocylindromas de-
noting the possible common histogenesis.1,7 Histologically
spiradenomas consist of one or more sharply delineated lar-
ge basophilic nodules within the dermis, sometimes exten-
ding into the subcutis, composed of trabeculae, sheets, cords
or islands with two main cell types: small epithelial basalo-
id cells with hyperchromatic nuclei at the periphery and lar-
ger cells with pale nuclei in the centre. Duct-like structures
can be observed within the lesions. Larger spiradenomas
may have a hyaline stroma and vascular ectasia. Unlike cy-
lindromas, they may be peppered with lymphocytes.1,7,12
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Although not observed in our patients, trichoepitheliomas
may also integrate the clinical spectrum of BSS. They are be-
nign neoplasms with follicular germinative differentiation.
Trichoepitheliomas classically occur as skin coloured papu-
les of themidface,mainly on the nose and nasolabial folds.1,2,8
Microscopically they consist of uniform basaloid cells with
peripheral palisading arranged in variably sized nodules or
nests, frequently in a cribriform pattern and with central ke-
ratinization of the infundibular type keratinization. These
cells are surrounded by a dense stroma containing papillary
mesenchymal bodies.12
Since BSS is an autosomal dominant genodermatosis, if
we assume that these sisters share the same germline mu-
tation, it becomes clear that there is a lack of genotype-phe-
notype correlation with mainly spiradenocylindromas in one
case and only cylindromas in the other. In fact, it has been
difficult to establish these correlations due to intra- and in-
terfamilial variability of the clinicopathologic manifestations
of BSS, highlighting the putative role of other genetic (e.g.
interaction of loss of heterozygosity or other somatic muta-
tions with germline CYLD mutations) or still unrecognized
epigenetic events.3,7
The clinical spectrum of BSS extends beyond the skin with
major and minor salivary glands being the most frequent lo-
cation of extracutaneous neoplasms, namely basal cell ade-
nomas and adenocarcinomas. Although this risk is low, their
evaluation is imperative.2,4 Ponti and colleagues recently re-
ported an ovarian Brenner tumor positive for a CYLDmuta-
tion in a BSS patient.6
So far there are no curative therapies for the skin lesions
of BSS. Various ablative and non-ablative techniques have
been used with variable results. Ideally they should be at-
tempted early to avoid disfiguring changes such as the tur-
ban tumor. The most common ablative therapies consist of
classical excision, dermoabrasion, CO
2
or erbium-YAG la-
sers, or cryotherapy.5,8 In the case of cylindromas, enucle-
ation has been successfully used for simultaneous but mini-
mally aggressive removal of multiple lesions.13
Total scalp excision followed by combined reconstruction
with artificial dermis and split skin graft has been used in tur-
ban tumor cases, with good results.10,14
Topical formulations containing salicylic acid or prosta-
glandin A1, which act by inhibiting NF-kB, are a possible non-
ablative treatment for solitary or small sized lesions.4,14,15
Conclusion
Early recognition of BSS is imperative, because of the po-
tential multiplicity of disfiguring lesions within members of
a family, the risk of malignant transformation, as well as the
association with other neoplasms. Genetic counselling and
dermatological evaluation should be provided in these cases.
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